Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
PROLOR BIOTECH (TASE: PBTH)
23.22 ILS  UNCHANGED
Daily Price  /  Updated: 9:24 AM EDT, May 16, 2013  /  Add to My Watchlist      
View: Quote News
All news about PROLOR BIOTECH
 
< Previous 1 2 3 4 5 6 Next >
Near Term Catalysts And High Insider Ownership Makes GTx An Attractive Buy
May 07, 2013
category Pharmaceuticals
from Trefis
PROLOR Biotech Inc (NYSE:PBTH) Investor Alert: Investigation of Takeover by OPKO Health, Inc
April 30, 2013
San Diego, CA -- (SBWIRE) -- 04/30/2013 -- An investigation on behalf of investors of PROLOR Biotech Inc (NYSEAMEX:PBTH) in connection with the proposed takeover was announced and NYSEAMEX:PBTH... Read More
from SBWire - Latest Press Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health
April 29, 2013
from PR Newswire
Bio-Wire Weekly: April 22 – April 26, 2013
April 29, 2013
Bio-Wire Weekly: April 22 – April 26, 2013 Good morning. Please sit, have a cup of coffee (or tea), and let’s go over last week’s action in the biotech & small pharma sector Note: get the weekly... Read More
category THRX , SRPT , CELG , and 9 more.
from Bio-Wire.Com
Lifshitz Law Firm Announces Investigation of Buckeye Technologies Inc., Intuitive Surgical, Inc., MPG Office Trust, Inc., and PROLOR Biotech, Inc.
April 28, 2013
from PR Newswire
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
April 27, 2013
from Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health
April 26, 2013
from Business Wire News Releases
PROLOR Biotech, Inc. Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Acquisition Agreement
April 26, 2013
from Business Wire News Releases
Law Firm Brower Piven Announces Investigation of PROLOR Biotech, Inc. Proposed Buyout
April 26, 2013
from Business Wire News Releases
Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout
April 25, 2013
from Business Wire News Releases
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
April 25, 2013
from PR Newswire
Biotech Takeovers Highlight Industry Growth
April 25, 2013
OPKO Health Inc. (NYSE:OPK) is set to take over Prolor Biotech Inc. (NYSE:PBTH) in the biotech industry's latest merger... Read More
from Wealth Daily
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of PROLOR Biotech, Inc. Shareholders
April 25, 2013
from Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health
April 25, 2013
from Business Wire News Releases
Ryan & Maniskas, LLP Announces Investigation of PROLOR Biotech, Inc.
April 25, 2013
from PR Newswire
PROLOR Biotech Investor Alert by Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates PROLOR Biotech, Inc. Following Announcement of Acquisition by OPKO Health, Inc. for Potential
April 24, 2013
from Business Wire News Releases
Acquisition of PROLOR Biotech, Inc. by OPKO Health, Inc. May Not Be in the Best Interests of PROLOR Shareholders
April 24, 2013
from PR Newswire
Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout
April 24, 2013
from Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PROLOR Biotech, Inc. - PBTH
April 24, 2013
from PR Newswire
US STOCKS-Dow slips, S&P edges up as durable goods, Apple drag
April 24, 2013
NEW YORK, April 24 (Reuters) - The Dow dipped while the S&P 500 edged up on Wednesday as a sharp drop in durable goods orders last month added to worries about slower U.S. economic activity and Apple's... Read More
category companyNews
from Reuters: Company News
Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of PROLOR Biotech, Inc.
April 24, 2013
from Business Wire News Releases
The Law Firm of Wohl & Fruchter Commences Investigation into the Acquisition of PROLOR Biotech, Inc. by OPKO Health, Inc.
April 24, 2013
from Business Wire News Releases
Law Firm Brower Piven Announces Investigation of PROLOR Biotech, Inc. Proposed Buyout
April 24, 2013
from Business Wire News Releases
Notable Mergers and Acquisitions of the Day 04/24: (BKI) (OPKO)/(PBTH)
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8274616 for the full story. Read More
from StreetInsider.com News Articles
Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders
April 24, 2013
from PR Newswire
StreetInsider.com Pre-Open Movers 4/24: (BKI) (IRBT) (YUM) Higher; (VOCS) (EW) (AAPL) Lower (more...)
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8274427 for the full story. Read More
from StreetInsider.com News Articles
OPKO Health (OPK) to Acquire PROLOR Biotech (PBTH)
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8273935 for the full story. Read More
from StreetInsider.com News Articles
US STOCKS-Futures climb on earnings lift, durable goods on tap
April 24, 2013
NEW YORK, April 24 (Reuters) - U.S. stock index futures rose modestly on Wednesday, indicating the S&P 500 may rise for a fourth straight day, as investors dealt with a host of corporate earnings... Read More
category companyNews
from Reuters: Company News
OPKO Health to buy Biotech company Prolor for $480 million
April 24, 2013
April 24 (Reuters) - OPKO Health Inc said it would buy biopharmaceutical company Prolor Biotech Inc in an all-stock deal to expand its portfolio of specialty drugs. Read More
category companyNews
from Reuters: Company News
OPKO Health To Acquire PROLOR Biotech
April 24, 2013
—Acquisition Adds Promising Late Stage Product hGH-CTP Targeting Growth Hormone Deficiency and Preclinical Products Targeting Hemophilia, Obesity & Diabetes— Read More
from PR Newswire
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here